ALEXANDRIA, Va., May 5 -- The United States Patent and Trademark Office (USPTO) published about the trademark 'REVLIMID' in its latest official gazette. The trademark application with the serial number 78290583 was filed on Aug. 21, 2003.
Here are the other related details:
Goods and Services: 5 - pharmaceutical preparations, namely, cytokine inhibitory drugs; pharmaceutical preparations that modulate the immune system
International/US Class(es): 5
Mark Drawing Code: 4 - STANDARD CHARACTER MARK
Current Owner(s): Celgene Corporation 86 Morris Avenue Summit NJ NEW JERSEY 07901 3 CORPORATION
Disclaimer: Curated by HT Syndication....